Search

Compugen Ltd

Cerrado

2.57 1.18

Resumen

Variación precio

24h

Actual

Mínimo

2.5300000000000002

Máximo

2.6

Métricas clave

By Trading Economics

Ingresos

663K

-7M

Ventas

426K

2.6M

P/B

Media del Sector

6.737

56.659

BPA

-0.07

Margen de beneficios

-269.254

Empleados

75

EBITDA

665K

-7M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+95.31% upside

Dividendos

By Acuity

Próximas Ganancias

9 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

17M

242M

Apertura anterior

1.39

Cierre anterior

2.57

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 sept 2026, 23:56 UTC

Correlated Moves

Macy's Inc shares are lower in after-market trading, influenced by a decline in Kohl's Corp and broader retail sector challenges.

4 sept 2026, 23:56 UTC

Southern Co. shares traded roughly flat in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

4 sept 2026, 23:56 UTC

Redwood Trust shares rose in after-market trading, amid rising Treasury yields and stable unemployment. The stock remains below its 20-day moving average.

4 sept 2026, 23:55 UTC

Mastercraft Boat Holdings Inc shares are higher in after-market hours. No specific news was identified to explain the movement.

4 sept 2026, 23:55 UTC

TE Connectivity PLC shares are higher in after-market trading. No specific company news was identified to explain this movement.

4 sept 2026, 23:55 UTC

Ameriprise Financial Inc shares are higher in after-market trading, influenced by stable labor market data and expectations for an interest rate hike.

4 sept 2026, 23:55 UTC

Incyte Corp shares are higher in after-market hours, reaching an early peak before settling back. No specific news was identified to explain the movement.

4 sept 2026, 23:55 UTC

Fastenal Co. shares moved higher in after-market trading, recovering from earlier losses amid rising Treasury yields and steady unemployment data.

4 sept 2026, 23:51 UTC

International Bancshares Corp. shares remained roughly flat during after-market hours, following four consecutive sessions of higher performance. No specific news was identified.

4 sept 2026, 23:51 UTC

Cytokinetics Inc shares are higher in after-market trading, reaching their highest cumulative return of the day, despite no specific news driving the move.

4 sept 2026, 23:51 UTC

Tecnoglass Inc shares are trading higher in after-market hours, marking five consecutive sessions of gains. No specific news was identified to explain the movement.

4 sept 2026, 23:51 UTC

CGI Inc shares are lower in after-market hours, continuing a decline since Friday's close. The stock remains significantly below its 20-day moving average.

4 sept 2026, 23:51 UTC

CME Group Inc shares are higher in after-market hours, reflecting strong performance as they approach the upper end of their one-month trading range.

4 sept 2026, 23:51 UTC

Axon Enterprise Inc shares are trading higher in after-market hours. No specific news was identified to explain this movement.

4 sept 2026, 23:51 UTC

Kohls Corp shares are lower in after-market hours amid weak trading and mixed economic signals, including rising unemployment and slowing wage growth.

4 sept 2026, 23:51 UTC

Nextera Energy Inc shares are lower in after-market hours, breaking a recent trend of higher daily closes amid a slight uptick in unemployment rates.

4 sept 2026, 23:51 UTC

EPR Properties shares are higher in after-market hours, reflecting unusual strength despite no specific company news amid mixed economic signals and interest rate expectations.

4 sept 2026, 23:51 UTC

Tapestry Inc shares are higher in after-market hours, recovering from an early dip. The stock remains below its 20-day moving average.

4 sept 2026, 23:51 UTC

ECB Set to Announce Deposit Facility Rate Hike Amid Inflation Concerns and Geopolitical Tensions on September 10, 2026.

4 sept 2026, 23:50 UTC

Wesco International Inc shares are higher in after-market hours, continuing a trend of recent gains and unusual trading activity noted earlier in the session.

4 sept 2026, 23:50 UTC

Weyerhaeuser Co shares are higher in after-market trading, reflecting an increase since Friday's close, despite remaining below the 20-day moving average.

4 sept 2026, 23:46 UTC

Antero Midstream Corp. shares showed little change during after-market hours, fluctuating within a narrow range and remaining above the 20-day moving average.

4 sept 2026, 23:46 UTC

Correlated Moves

US Bancorp shares are lower in after-market trading amid mixed macroeconomic signals and a decline in Live Oak Bancshares, reflecting broader market sentiments.

4 sept 2026, 23:46 UTC

Biogen Inc shares are lower in after-market hours, with no specific news driving the decline. Broader economic signals are contributing to market uncertainty.

4 sept 2026, 23:46 UTC

Enovix Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. Broader market dynamics influenced investor sentiment.

4 sept 2026, 23:45 UTC

Hershey Co. shares gained in after-market trading, reflecting routine performance amid broader market dynamics, despite earlier fluctuations after Friday's close.

4 sept 2026, 23:45 UTC

First American Financial shares higher in after-market trading, reflecting broader market movements amid shifting expectations for interest rates and recent economic data.

4 sept 2026, 23:45 UTC

Iron Mountain Inc is trading lower in after-market hours, with no specific news identified. The stock remains near its one-month low and below its 20-day moving average.

4 sept 2026, 23:45 UTC

Social Media

NIO Inc. CEO William Li discussed "operational quality" in a closed-door meeting. Shares traded roughly flat during after-market hours following the discussion.

4 sept 2026, 23:45 UTC

Lucid Group Inc. shares are trading lower in after-market hours, continuing a trend of weakness amid broader market declines and remaining below the 20-day moving average.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

95.31% repunte

Estimación a 12 Meses

Media 5 USD  95.31%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat